Latest filing published 09 Apr 2025 for 서린바이오.
한국증권금융: trading record in brief
All filings by 한국증권금융 on record concern 서린바이오. We count 6 filings; the first trade dates from 4 March 2021 and the latest from 31 January 2025.
In open-market terms, that means 5 purchases on one side and 1 sale on the other. The amount is not disclosed for 6 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2025 to date brings 1 purchase and 1 sale.
The 5 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The record was last updated on 9 April 2025 with an open-market sale in 서린바이오. The most recent open-market purchase was published on 9 January 2025, 668 days ago. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Companies and markets linked to 한국증권금융
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,491 sharesKRXDART:20210521000372Canonical exit: 19 Aug 2021 (T+90)
- 20,491 sharesKRXDART:20210412002362Canonical exit: 11 Jul 2021 (T+90)
- 20,491 sharesKRXDART:20210304000261Canonical exit: 2 Jun 2021 (T+90)
- 20,491 sharesKRXDART:20210304000249Canonical exit: 2 Jun 2021 (T+90)
6 of 6 declarations